Epoprostenol Mercury Pharmaceuticals Ltd

Epoprostenol Sodium is a medication used for specific cardiovascular conditions. It is administered intravenously and is manufactured by Mercury Pharmaceuticals Ltd. in the EU.

Epoprostenol Sodium is primarily used to improve symptoms in patients with pulmonary arterial hypertension. It works by dilating blood vessels, which helps to reduce the workload on the heart and improve blood flow. This medication is often prescribed for long-term management of the condition.

Common effects of Epoprostenol Sodium may include headache, nausea, and dizziness. Some users may also experience flushing or jaw pain. These effects are generally mild and temporary, but severe reactions should be reported to a healthcare provider immediately.

Epoprostenol Sodium should be handled with care and administered under medical supervision. It is important to follow the prescribed dosage and administration instructions to avoid complications. Patients with certain medical conditions or allergies should inform their healthcare provider before using this medication.

Epoprostenol Sodium may interact with other medications, including those that affect blood pressure or heart rate. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect the efficacy of this medication.